FilingPulse

ACET insider transaction filings

Adicet Bio, Inc. — 37 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-07. Screen ACET transaction legs live →

FiledFormInsiderReported transactionsSource
2026-08-074Klickstein Lloyd — Chief Medical Officer, DirectorGrant/award (A): 18,300 (derivative) @ $0EDGAR
2026-06-234Peng Katie — DirectorGrant/award (A): 4,200 (derivative) @ $0EDGAR
2026-06-234Aftab Blake — Chief Scientific OfficerGrant/award (A): 55,000 (derivative) @ $0EDGAR
2026-06-234Klickstein Lloyd — DirectorGrant/award (A): 4,200 (derivative) @ $0EDGAR
2026-06-234Sinclair Andrew — DirectorGrant/award (A): 4,200 (derivative) @ $0EDGAR
2026-06-234Grissinger Michael — DirectorGrant/award (A): 4,200 (derivative) @ $0EDGAR
2026-06-234Chodakewitz Jeffrey — DirectorGrant/award (A): 4,200 (derivative) @ $0EDGAR
2026-06-234Schor Chen — President & CEO, DirectorGrant/award (A): 55,000 (derivative) @ $0EDGAR
2026-06-234DUBIN STEVE — DirectorGrant/award (A): 4,200 (derivative) @ $0EDGAR
2026-04-294RA CAPITAL MANAGEMENT, L.P. — 10% owner
RA Capital Healthcare Fund LP — 10% owner
Kolchinsky Peter — 10% owner
Shah Rajeev M. — 10% owner		Other (J): 250,000 · Other (J): 250,000 (derivative)EDGAR
2026-04-134RA CAPITAL MANAGEMENT, L.P. — 10% owner
RA Capital Healthcare Fund LP — 10% owner
Kolchinsky Peter — 10% owner
Shah Rajeev M. — 10% owner		Purchase (P): 74,577 @ $7.04 · Purchase (P): 74,268 @ $7.21 · Purchase (P): 74,751 @ $7.27EDGAR
2026-04-094ORBIMED ADVISORS LLC — 10% owner
OrbiMed Capital GP V LLC — 10% owner
OrbiMed Capital GP VI LLC — 10% owner
OrbiMed Genesis GP LLC — 10% owner
OrbiMed Advisors Israel II Ltd — 10% owner
OrbiMed Israel GP II, L.P. — 10% owner
OrbiMed Israel GP Ltd. — 10% owner
OrbiMed Israel BioFund GP Limited Partnership — 10% owner		Sale (S): 29,319 @ $6.53 · Sale (S): 2,400 @ $6.38 · Sale (S): 32,523 @ $6.29 · Sale (S): 40,416 @ $6.52EDGAR
2026-03-274Maltzman Julia D. — Chief Medical OfficerGrant/award (A): 72,555 (derivative) @ $0EDGAR
2026-03-274Aftab Blake — Chief Scientific OfficerGrant/award (A): 72,555 (derivative) @ $0EDGAR
2026-03-274Healey Don — Chief Technology OfficerGrant/award (A): 43,361 (derivative) @ $0EDGAR
2026-03-274Harvey Brian Nicholas — Chief Financial OfficerGrant/award (A): 43,361 (derivative) @ $0EDGAR
2026-03-274Schor Chen — President & CEO, DirectorGrant/award (A): 468,555 (derivative) @ $0EDGAR
2026-01-274Aftab Blake — Chief Scientific OfficerTax withholding (F): 535 @ $8.44EDGAR
2026-01-274Healey Don — Chief Technology OfficerTax withholding (F): 535 @ $8.44EDGAR
2026-01-274Harvey Brian Nicholas — Chief Financial OfficerTax withholding (F): 546 @ $8.44EDGAR
2026-01-274Schor Chen — President & CEO, DirectorTax withholding (F): 1,755 @ $8.44EDGAR
2025-10-104ORBIMED ADVISORS LLC — 10% owner
OrbiMed Capital GP V LLC — 10% owner
OrbiMed Capital GP VI LLC — 10% owner
OrbiMed Genesis GP LLC — 10% owner
OrbiMed Advisors Israel II Ltd — 10% owner
OrbiMed Israel GP II, L.P. — 10% owner
OrbiMed Israel GP Ltd. — 10% owner
OrbiMed Israel BioFund GP Limited Partnership — 10% owner		Purchase (P): 1,500,000 @ $1 · Purchase (P): 3,500,000 @ $1EDGAR
2025-06-134Klickstein Lloyd — DirectorGrant/award (A): 5,900 @ $0 · Grant/award (A): 26,400 (derivative) @ $0EDGAR
2025-06-134Peng Katie — DirectorGrant/award (A): 5,900 @ $0 · Grant/award (A): 26,400 (derivative) @ $0EDGAR
2025-06-134Sinclair Andrew — DirectorGrant/award (A): 5,900 @ $0 · Grant/award (A): 26,400 (derivative) @ $0EDGAR
2025-06-134Chodakewitz Jeffrey — DirectorGrant/award (A): 5,900 @ $0 · Grant/award (A): 26,400 (derivative) @ $0EDGAR
2025-06-134DUBIN STEVE — DirectorGrant/award (A): 5,900 @ $0 · Grant/award (A): 26,400 (derivative) @ $0EDGAR
2025-04-214Grissinger Michael — DirectorGrant/award (A): 70,200 (derivative) @ $0EDGAR
2025-02-044Aftab Blake — Chief Scientific OfficerGrant/award (A): 275,000 (derivative) @ $0EDGAR
2025-02-044Maltzman Julia D. — Chief Medical OfficerGrant/award (A): 750,000 (derivative) @ $0EDGAR
2025-02-044Healey Don — Chief Technology OfficerGrant/award (A): 275,000 (derivative) @ $0EDGAR
2025-02-044Harvey Brian Nicholas — Chief Financial OfficerGrant/award (A): 324,040 (derivative) @ $0EDGAR
2025-02-044Schor Chen — President & CEO, DirectorGrant/award (A): 763,829 (derivative) @ $0EDGAR
2025-01-284Aftab Blake — Chief Scientific OfficerTax withholding (F): 6,270 @ $0.92EDGAR
2025-01-284Healey Don — Chief Technology OfficerTax withholding (F): 8,560 @ $0.92EDGAR
2025-01-284Harvey Brian Nicholas — Chief Financial OfficerTax withholding (F): 8,752 @ $0.92EDGAR
2025-01-284Schor Chen — President & CEO, DirectorTax withholding (F): 28,101 @ $0.92EDGAR

Recent 8-K events — Adicet Bio, Inc.

FiledFormItems reportedSource
2026-08-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-188-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-04-288-K3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits		EDGAR
2026-03-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-01-078-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2025-12-298-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2025-12-198-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2025-11-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2025-10-078-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ACET returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →